Author： Chojnacki Jakub Grgacic Elizabeth VL
Publisher： Future Medicine
ISSN： 1746-0794
Source： Future Virology, Vol.3, Iss.6, 2008-11, pp. : 543-552
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Treatment of viral hepatitis B in children
By Giacchino Raffaella Cappelli Barbara
Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 6, 2010-04 ,pp. :
Access to resources
Recommend
Nuclear factor kappa B and hepatitis viruses
By Guan Yong-Song He Qing Wang Ming-Quan Li Ping
Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 3, 2008-03 ,pp. :
Modeling infection with hepatitis B viruses in vivo
By Dandri Maura Volz Tassilo Lutgehetmann Marc Petersen Jorg
Future Virology, Vol. 1, Iss. 4, 2006-07 ,pp. :
Host-range and pathogenicity of hepatitis B viruses
By Netter Hans-Jüürgen Chang Shau-Feng Bruns Michael
Future Virology, Vol. 3, Iss. 1, 2008-01 ,pp. :
Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion
Current Medicinal Chemistry, Vol. 15, Iss. 10, 2008-04 ,pp. :